Calciforti
Natural health product licensed in Canada
- Licence holder
- Garlian Global Inc.
- NPN or DIN-HM
- 80060570
- Status
- Active licence
- Licence date
- 5 May 2015
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol | 10 microgrammes | Not calculated |
| Calcium Source : Carbonate de calcium | 200 milligramme | 400,000 µg |
| Calcium Source : Coquille d'huître | 200 milligramme | 400,000 µg |
| Magnésium Source : Oxyde de magnésium | 100 milligramme | 200,000 µg |
Non-medicinal ingredients
Gélatine, Dioxyde de titane, Huile végétale, Glycérine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et Adolescents | minimum: 4 years ; maximum: 18 years | 1 Capsule | 1 Tous les jours |
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones and teeth, especially in childhood, adolescence and young adulthood. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps the body to metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps to maintain proper muscle function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience diarrhea when taking magnesium doses greater than 350mg per day.
Source
Official Health Canada record, licence 80060570
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.